These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9291997)

  • 1. A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease.
    Recanatini M; Cavalli A; Hansch C
    Chem Biol Interact; 1997 Aug; 105(3):199-228. PubMed ID: 9291997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors.
    Ul-Haq Z; Mahmood U; Jehangir B
    Chem Biol Drug Des; 2009 Dec; 74(6):571-81. PubMed ID: 19843075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and
    David B; Schneider P; Schäfer P; Pietruszka J; Gohlke H
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):491-496. PubMed ID: 33478277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of acetylcholinesterase by physostigmine analogs: conformational mobility of cysteine loop due to the steric effect of the alkyl chain.
    Gavuzzo E; Pomponi M
    J Biochem Mol Toxicol; 2002; 16(2):64-9. PubMed ID: 11979423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure -- activity relationships (QSARs) of thrombin inhibitors: review, evaluation and comparative analysis.
    Kontogiorgis C; Hadjipavlou - Litina D
    Curr Med Chem; 2003 Apr; 10(7):525-77. PubMed ID: 12678789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
    Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
    J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.
    Czarnecka K; Chufarova N; Halczuk K; Maciejewska K; Girek M; Skibiński R; Jończyk J; Bajda M; Kabziński J; Majsterek I; Szymański P
    Eur J Med Chem; 2018 Feb; 145():760-769. PubMed ID: 29353726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation.
    Mao F; Huang L; Luo Z; Liu A; Lu C; Xie Z; Li X
    Bioorg Med Chem; 2012 Oct; 20(19):5884-92. PubMed ID: 22944335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease.
    Greig NH; Pei XF; Soncrant TT; Ingram DK; Brossi A
    Med Res Rev; 1995 Jan; 15(1):3-31. PubMed ID: 7898167
    [No Abstract]   [Full Text] [Related]  

  • 10. SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.
    Recanatini M; Cavalli A; Belluti F; Piazzi L; Rampa A; Bisi A; Gobbi S; Valenti P; Andrisano V; Bartolini M; Cavrini V
    J Med Chem; 2000 May; 43(10):2007-18. PubMed ID: 10821713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.
    Shinada M; Narumi F; Osada Y; Matsumoto K; Yoshida T; Higuchi K; Kawasaki T; Tanaka H; Satoh M
    Bioorg Med Chem; 2012 Aug; 20(16):4901-14. PubMed ID: 22831800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives.
    Mohammadi-Khanaposhtani M; Saeedi M; Zafarghandi NS; Mahdavi M; Sabourian R; Razkenari EK; Alinezhad H; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T
    Eur J Med Chem; 2015 Mar; 92():799-806. PubMed ID: 25636055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR applications during last decade on inhibitors of acetylcholinesterase in Alzheimer's disease.
    Wong KY; Duchowicz PR; Mercader AG; Castro EA
    Mini Rev Med Chem; 2012 Sep; 12(10):936-46. PubMed ID: 22303974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
    Kaur J; Zhang MQ
    Curr Med Chem; 2000 Mar; 7(3):273-94. PubMed ID: 10637365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenserine Axonyx.
    Thatte U
    Curr Opin Investig Drugs; 2005 Jul; 6(7):729-39. PubMed ID: 16044670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.
    Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH
    J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
    Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase.
    Perola E; Cellai L; Lamba D; Filocamo L; Brufani M
    Biochim Biophys Acta; 1997 Nov; 1343(1):41-50. PubMed ID: 9428657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
    Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y
    Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.